Home

Gänseblümchen Computer Spitzname nmd pharma aps Band Kampf Draht

Venture capital and start-ups in Denmark. Capital matches opportunity.  February 2020
Venture capital and start-ups in Denmark. Capital matches opportunity. February 2020

About - InsuSense Therapeutics
About - InsuSense Therapeutics

NMD Pharma ApS Annual Report for 1 January - 31 December 2017
NMD Pharma ApS Annual Report for 1 January - 31 December 2017

Lundbeckfonden Annual Report 2016
Lundbeckfonden Annual Report 2016

Lars Knutsen's email & phone | NMD Pharma ApS's VP, Medicinal Chemistry  email
Lars Knutsen's email & phone | NMD Pharma ApS's VP, Medicinal Chemistry email

NMD Pharma
NMD Pharma

Investors — NMD Pharma
Investors — NMD Pharma

Martin Broch-Lips - Scientific Project Manager - NMD Pharma APS | LinkedIn
Martin Broch-Lips - Scientific Project Manager - NMD Pharma APS | LinkedIn

Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email

Annual Report 2019 by Lundbeckfonden - issuu
Annual Report 2019 by Lundbeckfonden - issuu

Annual Report 2018 by Lundbeckfonden - issuu
Annual Report 2018 by Lundbeckfonden - issuu

EP2355810B1 - Composé pour le traitement de la psoriasis - Google Patents
EP2355810B1 - Composé pour le traitement de la psoriasis - Google Patents

PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO  SHAREHOLDERS IN SANIONA AB
PROPOSED DISTRIBUTION OF SANIONA AB'S SHARES IN INITIATOR PHARMA A/S TO SHAREHOLDERS IN SANIONA AB

Management — NMD Pharma
Management — NMD Pharma

Contact — NMD Pharma
Contact — NMD Pharma

Annual Report 2018 by Lundbeckfonden - issuu
Annual Report 2018 by Lundbeckfonden - issuu

Management — NMD Pharma
Management — NMD Pharma

Investors — NMD Pharma
Investors — NMD Pharma

NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark

NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark

Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person  Profile
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile

EP2355810B1 - Composé pour le traitement de la psoriasis - Google Patents
EP2355810B1 - Composé pour le traitement de la psoriasis - Google Patents

NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark

Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn
Claus Olesen - Co-Founder - STipe Therapeutics | LinkedIn

NMD Pharma
NMD Pharma

News — NMD Pharma
News — NMD Pharma

Management — NMD Pharma
Management — NMD Pharma

Investors — NMD Pharma
Investors — NMD Pharma